|
May 15
|
PharmaDrug's Sairiyo Therapeutics Submits Clinical Trial Application for Phase 1 Study of Patented Reformulated Cepharanthine
|
|
May 15
|
PharmaTher’s Sairiyo Therapeutics Submits Clinical Trial Application for Phase 1 Study of Patented Reformulated Cepharanthine
|
|
May 13
|
PharmaDrug Provides Forward Plan to Move Its Patent Pending Process and Formulation of Pharmaceutical Grade Biosynthetic Cocaine Through Development into Commercialization
|
|
Sep 6
|
PharmaDrug Announces Appointment of CEO and Changes to the Board of Directors
|
|
Jul 5
|
PharmaDrug Announces Termination of General Security Agreement and Issuance of Common Shares
|